JB Chemicals & Pharmaceuticals Q4 Results: Company reports 43% increase in PAT to Rs 126 crore
Revenue increased to Rs 862 crore in the fourth quarter as against Rs 762 crore in the year-ago period, JB Chemicals & Pharmaceuticals said in a statement. For the year ended March 31, 2024, the company said its PAT increased 35 per cent to Rs 553 crore as compared with Rs 410 crore in FY23.
JB Chemicals & Pharmaceuticals on Friday said its profit after tax (PAT) increased 43 per cent to Rs 126 crore in the March quarter, driven by strong sales. The drug maker had reported a PAT of Rs 88 crore in the March quarter of FY23.
Revenue increased to Rs 862 crore in the fourth quarter as against Rs 762 crore in the year-ago period, JB Chemicals & Pharmaceuticals said in a statement. For the year ended March 31, 2024, the company said its PAT increased 35 per cent to Rs 553 crore as compared with Rs 410 crore in FY23. Revenue increased to Rs 3,484 crore in last fiscal as against Rs 3,149 crore in 2022-23 fiscal.
"The company continued its momentum in the quarter with market beating growth in domestic business. With strong focus on our leading brands, we continue to drive higher than market volume growth and gain share in our core therapeutic areas," JB Pharma CEO Nikhil Chopra said.
The focus on improving business mix and cost management strategies, has helped international business improve overall operating margins despite increase in freight costs on account of geo-political issues, he added.
"With continued thrust on domestic and CDMO (Contract Development and Manufacturing Organizations) businesses, we feel confident that the company will continue to deliver sustained revenue growth and improved operating margins in the medium to long term," Chopra said.
Shares of drug firm on Friday ended 0.45 per cent down to Rs 1,823.85 apiece on the BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000
Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations
Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here
Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others
New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets
09:40 PM IST